Nanomedicine News

RSS

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.

From Massachusetts Institute of Technology 9 May 2014

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

NanoViricides, Inc. (the "Company") reported today that it has designed and synthesized novel nanoviricides® drug candidates in quantities sufficient for testing in animals infected with the MERS Corona Virus.

From NanoViricides, Inc 7 May 2014

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Azaya Therapeutics, Inc., a clinical-stage oncology company developing safer and more effective cancer treatments through its nanotechnology platform, announced a collaboration with the University of Chicago, in Chicago, Illinois.

7 May 2014

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Capricor Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced the execution of an Exclusive License Agreement with Cedars-Sinai Medical Center for intellectual property (IP) related to the development of exosomes.

7 May 2014

Two Keys Open Tunable Virus That Works Like a Safe Deposit Box

Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.

7 May 2014

Cystinosis Research Foundation Raises $2.3 Million for New Research Using Nanotechnology

The Cystinosis Research Foundation raised a record $2.3 million at its annual fundraiser for new research to improve cystinosis treatments and continue progress to cure the rare metabolic disease. Cystinosis destroys the body’s organs and afflicts about 2,000 people, mostly children, worldwide.

6 May 2014

pSivida Presents Poster on ‘Sustained Release of Bevacizumab from BioSilicon’ at 14th ARVO

pSivida Corp., a leader in the development of sustained release products for treating eye diseases, today announced that the Company presented the first peer-reviewed preclinical data demonstrating the use of pSivida’s Tethadur™ technology to provide sustained release of Avastin at the 14th Annual Meeting of ARVO (Association for Research in Vision and Ophthalmology).

From EyePoint Pharmaceuticals, Inc. 6 May 2014

MagForce Holds Meeting with FDA Center for Devices and Radiological Health for NanoTherm Therapy Pre-Submission

MagForce AG (Frankfurt, Entry Standard), a leading medical device company in the field of nanomedicine focused on oncology, together with its subsidiary MagForce USA, Inc. are pleased to report that an in-person meeting was held with the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health to discuss FDA's response to MagForce's NanoTherm® Therapy Pre-Submission of late December, 2013.

6 May 2014

Researchers Receive Funding to Explore Ways to Improve Heart Disease Treatment Using Nanoparticles

A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received £3 million funding.

2 May 2014

Liquidia to Report Study Results on Next-Generation Multivalent PRINT Nanoparticle Pneumococcal Vaccine

Liquidia Technologies today announced that it will present findings from preclinical proof-of-concept studies conducted with its next generation, multivalent pneumococcal vaccine that is based on the company’s novel PRINT® (Particle Replication In Non-Wetting Templates) technology.

From Liquidia Technologies, Inc. 2 May 2014

Nanomedicine News

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Two Keys Open Tunable Virus That Works Like a Safe Deposit Box

Cystinosis Research Foundation Raises $2.3 Million for New Research Using Nanotechnology

pSivida Presents Poster on ‘Sustained Release of Bevacizumab from BioSilicon’ at 14th ARVO

MagForce Holds Meeting with FDA Center for Devices and Radiological Health for NanoTherm Therapy Pre-Submission

Researchers Receive Funding to Explore Ways to Improve Heart Disease Treatment Using Nanoparticles

Liquidia to Report Study Results on Next-Generation Multivalent PRINT Nanoparticle Pneumococcal Vaccine

Cigarette Waste as a Source for Sustainable Supercapacitors

Laser-Induced Graphene for Printable and Biomedical Applications

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Novel Technique Dramatically Increases Graphene's Elasticity

Nanotubes Stabilize Carbyne, Paving Way for Advanced Electronics

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination